Back
C4 Therapeutics Stock Price Chart
Sponsored
CCCC
Sponsored
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
20
CCCC
C4 Therapeutics
Last Price:
5.51
Seasonality Move:
60.44%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CCCC is experiencing slight selling pressure.
C4 Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.93 | Sell |
20-day SMA: | 6.04 | Sell |
50-day SMA: | 5.95 | Sell |
200-day SMA: | 6.47 | Sell |
8-day EMA: | 5.96 | Sell |
20-day EMA: | 5.94 | Sell |
50-day EMA: | 5.94 | Sell |
200-day EMA: | 5.86 | Buy |
C4 Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 49.02 | Sell |
Chaikin Money Flow: | -338413 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.42 - 6.32) | Buy |
Bollinger Bands (100): | (5.19 - 6.51) | Buy |
C4 Therapeutics Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for C4 Therapeutics Stock
Is C4 Therapeutics Stock a Buy?
- C4 Therapeutics share price is 5.89 while CCCC 8-day simple moving average is 5.93, which is a Sell signal.
- The stock price of CCCC is 5.89 while C4 Therapeutics 20-day SMA is 6.04, which makes it a Sell.
- C4 Therapeutics 50-day simple moving average is 5.95 while CCCC share price is 5.89, making it a Sell technically.
- CCCC stock price is 5.89 and C4 Therapeutics 200-day simple moving average is 6.47, creating a Sell signal.
CCCC Technical Analysis vs Fundamental Analysis
Sell
20
C4 Therapeutics (CCCC)
is a Sell
Is C4 Therapeutics a Buy or a Sell?
-
C4 Therapeutics stock is rated a Sell
The current C4 Therapeutics [CCCC] share price is $5.89. The Score for CCCC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
C4 Therapeutics Stock Info
Market Cap:
415.77M
Price in USD:
5.89
Share Volume:
827.23K
C4 Therapeutics 52-Week Range
52-Week High:
11.88
52-Week Low:
1.06
Sell
20
C4 Therapeutics (CCCC)
is a Sell
C4 Therapeutics Share Price Forecast
-
What is the C4 Therapeutics stock price today?
The C4 Therapeutics stock price is 5.89 USD today. -
Will CCCC stock go up or go down?
C4 Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is C4 Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, C4 Therapeutics is overvalued.
Is C4 Therapeutics Stock a Buy?
- C4 Therapeutics share price is 5.89 while CCCC 8-day exponential moving average is 5.96, which is a Sell signal.
- The stock price of CCCC is 5.89 while C4 Therapeutics 20-day EMA is 5.94, which makes it a Sell.
- C4 Therapeutics 50-day exponential moving average is 5.94 while CCCC share price is 5.89, making it a Sell technically.
- CCCC stock price is 5.89 and C4 Therapeutics 200-day simple moving average is 5.86, creating a Buy signal.
Fundamental Analysis of C4 Therapeutics
Is C4 Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and an increase next year of $0.35 per share.
Technical Analysis of C4 Therapeutics
Should I short C4 Therapeutics stock?
- CCCC Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting C4 Therapeutics is a Buy
- C4 Therapeutics Relative Strength Index (RSI) is 49.02, which suggest C4 Therapeutics is oversold
- The Bollinger Bands (25) for C4 Therapeutics is (5.42 - 6.32), which suggest C4 Therapeutics is a Buy
- The Bollinger Bands (100) for C4 Therapeutics is (5.19 - 6.51), which suggest C4 Therapeutics is a Buy
* C4 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.